Multiply your biomarker profiling power with multimodal sequencing

Recent advances in NGS and bioinformatics have empowered researchers to simultaneously sequence DNA and RNA from biological samples. However, current approaches require two separate workflows for DNA and RNA library preps, which call for higher input materials, longer turnaround times and increased costs .

One sample, flexible options—to accelerate your multiomic studies

With QIAseq Multimodal technology, you can take a whole-omics approach (whole genome and whole transcriptome) or a targeted approach by amplicon- or hybrid capture-based enrichment, to examine DNA and RNA analytes. The automation-friendly workflows enable simultaneous profiling of DNA and RNA biomarkers from a single sample to accelerate your multiomic studies. Moreover, QIAseq Multimodal chemistries facilitate reliable and sensitive detection of variants from a diverse array of sample types and require as little as 10 ng of input.  

Comprehensive genomic profiling (CGP) is dramatically changing our understanding of various cancers, revealing an unprecedented level of detail. Multimodal sequencing can accelerate this rapidly evolving field of research.

Top 3 reasons to adopt a multimodal approach for CGP:

1. Save time and resources: Consolidate separate workflows into a single-day, sample to sequencing workflow.
2. Conserve precious samples: Simultaneously profile multiple DNA and RNA biomarkers, TMB and MSI from a single, low-input sample.
3. Get deeper insights: Achieve a holistic view of various DNA and RNA biomarkers efficiently.